SteadyMed Launches IPO
SAN RAMON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the launch of its initial public offering of 4,250,000 ordinary shares at an...
View ArticleCancer Biotech Cellectis Sets Terms For $129 Million IPO
Cellectis, which is developing cancer immunotherapies based on gene-edited CAR T-cells, announced terms for its US offering on Wednesday.The Paris, France-based company plans to raise $129 million by...
View ArticleZhejiang ChiMin Pharma Stages $47 Million IPO In Shanghai
Zhejiang ChiMin Pharma recently completed an IPO on the Shanghai Stock Exchange, raising $47.4 million. The company specializes in generic IV solution drugs. ChiMin has been designated a National...
View ArticleSteadyMed Announces Closing of Initial Public Offering
SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...
View ArticleApplied DNA Sciences, Inc. Prices $11.46 Million Public Offering
STONY BROOK, NY--(Marketwired - March 27, 2015) - Applied DNA Sciences, Inc. (APDN)(APDNW) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product...
View ArticleBone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues
March 27, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor...
View ArticleCancer Gene Therapy Biotech Files for a $70M IPO
MultiVir Files Registration Statement for Proposed Initial Public OfferingHOUSTON, March 30, 2015 /PRNewswire/ --MultiVir Inc. ("MultiVir"), a clinical-stage gene therapy company developing a pipeline...
View ArticleAfter Exiting RTP, CoLucid Pharma Files with for $86M IPO
March 31, 2015By Krystle Vermes, BioSpace.com Breaking News StaffSince abruptly...
View ArticleBotox Biotech Anterios Files For A $58 Million IPO
Anterios, which is developing a topical formulation of botulinum toxin, filed on Tuesday with the SEC to raise up to $58 million in an initial public offering.Revance Therapeutics (RVNC), which is also...
View ArticleaTyr Pharma $76 Million Series E Gets IPO Rumors Flying
April 1, 2015By Mark Terry, BioSpace.com Breaking...
View ArticleIPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the...
April 6, 2015By Riley McDermid...
View ArticleKemPharm Sets Terms for $52 Million IPO
KemPharm, which is developing abuse-deterrent versions of widely-prescribed pain medications, announced terms for its IPO on Friday. The Coralville, IA-based company plans to raise $52 million by...
View ArticleAduro Biotech Launches $119 Million IPO with Hot Cancer Tech
April 15, 2015By Mark Terry and
View ArticleShanghai Haohai Biological To Stage $305 Million IPO In Hong Kong
Shanghai Haohai Biological Technology, a company that makes medical products from absorbable biomedical materials, announced plans to raise as much as $305 million in an IPO on the Hong Kong Stock...
View ArticleAs Market Froths, Blueprint Medicines Debuts $147 Million IPO for...
April 30, 2015By Riley McDermid
View ArticleBlueprint Medicines Announces Closing of Initial Public Offering
CAMBRIDGE, Mass., May 5, 2015 /PRNewswire/ --Blueprint Medicines (NASDAQ: BPMC) today announced the closing of its initial public offering of 9,367,708 shares of common stock at a public offering price...
View ArticleAdaptimmune Announces Pricing Of IPO
OXFORD, United Kingdom and PHILADELPHIA, May 6, 2015 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) today announced the pricing of its initial public offering of 11,250,000 American...
View ArticleGW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of...
LONDON, May 5, 2015 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel...
View ArticleCollegium Announces Pricing Of Its IPO
CANTON, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc., (Nasdaq:COLL) today announced the pricing of its initial public offering of 5,800,000 shares of its common stock at a...
View ArticleaTyr Pharma Announces Pricing Of Initial Public Offering
SAN DIEGO, May 6, 2015 /PRNewswire/ --aTyr Pharma, Inc. ("aTyr"), today announced the pricing of its initial public offering of 5,360,000 shares of its common stock at an initial public offering price...
View Article
More Pages to Explore .....